In 2011, we were one of the first users of ReLEx® SMILE globally.
- Painless correction of myopia and astigmatism
- For patients having problems with contact lenses or dry eyes
- Performed more than 2 million times globally
To enable us to treat or operate your eyes gently and painlessly, our ophthalmologists are also working scientifically. As a co-operation partner in the IVCRC.net of the UniversitätsAugenklinik Heidelberg, we are executing our own research projects. Our experienced ophthalmologists and eye surgeons in Düsseldorf will be happy to assist you. Please make an appointment.
Implantable contact lenses
At the ESCRS congress, Dr. Breyer performs a live implantation of the Visian ICL contact lens with a micro incision of 1.8 mm as the first person in the whole world.
UV Cross linking
Dr. Breyer is among the pioniers to treat keratoconus with the UV Cross linking.
Dr. Breyer implanted a toric intraocular lens through a 1.8-mm micro incision for treatment of a cataract and correction of astigmatism as the first person in the whole world.
Dr. Breyer is one of the 10 first users of ReLEx® SMILE globally. His work has been recognized in the international scientific community.
Laser Blended Vision
Dr. Breyer offers as one of the first Eye Surgeons Laser Blended Vision (Presbyond) to treat Presbyopia.
In Europe, we are among the first five practices to operate cataracts with the femtosecond laser.
Dr. Klabe is among the first doctors exclusively performing all modern glaucoma surgery procedures on an outpatient basis, in particular the minimally invasive glaucoma operation.
Dr. Kaymak implants the first special AMD lens in Europe.
Dr. Kaymak and Roxana Fulga are among the first users of augenchirurgie.clinic/en/treatments/laser-vitreolyse text: laser vitreolysis globally.
Globally, Dr. Kaymak is one of the pioneers treating macular disorders by gentle Nano-laser therapy.
Glaucoma micro implants
As one of the first doctors to do so, Dr. Klabe implanted the micro implants iStent-Inject and XEN. Dr. Klabe is appointed to the European and German advisory board for the XEN implant.
Dr. Breyer is awarded a prize for his Düsseldorf formula by the congress of European eye surgeons.
As a matter of routine, Dr. Kaymak uses the low-dosage atropine therapy in myopic children and adolescents. He has been researching this topic for 20 years.
Dr. Breyer is awarded a Sci-Tech Award: 3D vision is very good with the Düsseldorf formula.
Dr. Klabe becomes a member of the European and German advisory board for the Cypass, a micro implant for surgical treatment of glaucoma.